BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17698986)

  • 1. A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects.
    Weickert MO; Loeffelholz CV; Roden M; Chandramouli V; Brehm A; Nowotny P; Osterhoff MA; Isken F; Spranger J; Landau BR; Pfeiffer AF; Möhlig M
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1078-84. PubMed ID: 17698986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fatty acid binding protein gene ablation potentiates hepatic cholesterol accumulation in cholesterol-fed female mice.
    Martin GG; Atshaves BP; McIntosh AL; Mackie JT; Kier AB; Schroeder F
    Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G36-48. PubMed ID: 16123197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute elevation of free fatty acids impairs hepatic glucose uptake in conscious rats.
    Nakahara I; Matsuhisa M; Shiba Y; Kuroda A; Nakatani Y; Hatazaki M; Kajimoto Y; Kubota M; Yamasaki Y; Hori M
    Diabetes Res Clin Pract; 2004 Nov; 66(2):109-18. PubMed ID: 15533577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
    Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
    Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
    Guy DA; Sandoval D; Richardson MA; Tate D; Flakoll PJ; Davis SN
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of colostrum feeding and glucocorticoid administration on insulin-dependent glucose metabolism in neonatal calves.
    Scheuer BH; Zbinden Y; Schneiter P; Tappy L; Blum JW; Hammon HM
    Domest Anim Endocrinol; 2006 Oct; 31(3):227-45. PubMed ID: 16360295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
    Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
    Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fat and lipid oxidation in humans.
    Kotronen A; Seppälä-Lindroos A; Vehkavaara S; Bergholm R; Frayn KN; Fielding BA; Yki-Järvinen H
    Liver Int; 2009 Oct; 29(9):1439-46. PubMed ID: 19602132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between adipocyte fatty acid-binding protein levels and childhood obesity in Korean children.
    Yun KE; Kim SM; Choi KM; Park HS
    Metabolism; 2009 Jun; 58(6):798-802. PubMed ID: 19368945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered hepatic gluconeogenesis during L-alanine infusion in weight-losing lung cancer patients as observed by phosphorus magnetic resonance spectroscopy and turnover measurements.
    Leij-Halfwerk S; van den Berg JW; Sijens PE; Wilson JH; Oudkerk M; Dagnelie PC
    Cancer Res; 2000 Feb; 60(3):618-23. PubMed ID: 10676645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise.
    Shearer J; Fueger PT; Rottman JN; Bracy DP; Binas B; Wasserman DH
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E292-7. PubMed ID: 15454399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hepatic and brain metabolism in young adults with glycogen storage disease type 1: a magnetic resonance spectroscopy study.
    Weghuber D; Mandl M; Krssák M; Roden M; Nowotny P; Brehm A; Krebs M; Widhalm K; Bischof MG
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1378-84. PubMed ID: 17785500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of critical factors influencing gene expression of two types of fatty acid-binding proteins (L-FABP and Lb-FABP) in the liver of birds.
    Murai A; Furuse M; Kitaguchi K; Kusumoto K; Nakanishi Y; Kobayashi M; Horio F
    Comp Biochem Physiol A Mol Integr Physiol; 2009 Oct; 154(2):216-23. PubMed ID: 19540927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
    Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
    Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fatty acids on hepatic amino acid catabolism and fibrinogen synthesis in young healthy volunteers.
    Freyse EJ; Giessmann T; Petzke KJ; Knospe S; Engel G; Heinke P; Metges CC; Siegmund W
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E54-62. PubMed ID: 12791602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.